Medicare Enrolled
Dr. Rafael Aguila, MD
Family Medicine · Warner Robins, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Aguila from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Aguila?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Aguila
Dr. Rafael Aguila is a family medicine specialist in Warner Robins, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Aguila performed 6,197 Medicare services across 2,832 unique beneficiaries.
Between the years covered by Open Payments, Dr. Aguila received a total of $9,615 from 67 pharmaceutical and/or device companies across 594 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Aguila is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 4% volume in GA
$9,615 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,197
Medicare services
Top 4% in GA for family medicine
2,832
Unique beneficiaries
$47
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~326 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
947 | $80 | $185 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
717 | $44 | $119 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
550 | $14 | $54 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
519 | $55 | $118 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
513 | $35 | $133 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
408 | $35 | $92 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
379 | $34 | $120 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
366 | $29 | $106 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
274 | $114 | $177 |
| Obesity behavioral counseling, 15 minutes A 15-minute face-to-face session focused on behavioral counseling to help manage obesity. |
268 | $24 | $49 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
265 | $75 | $123 |
| Annual depression screening | 260 | $17 | $48 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
161 | $3 | $24 |
| Additional chronic care management time, 60 minutes This service covers an additional 60 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions, billed per calendar month. |
132 | $52 | $123 |
| Complex chronic care management, first 60 minutes This service involves clinical staff time directed by a healthcare professional to manage two or more chronic conditions over a calendar month. It covers the first 60 minutes of this coordinated care effort. |
80 | $98 | $220 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
66 | $10 | $45 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
56 | $3 | $28 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
40 | $12 | $40 |
| Urine microalbumin test (kidney screening) A laboratory test that measures the amount of microalbumin, a small protein, in a urine sample. This test is used to detect early signs of kidney damage. |
35 | $6 | $50 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
35 | $64 | $155 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
31 | $32 | $90 |
| Drug test with direct observation A drug screening test performed under direct observation to ensure the sample is provided correctly. This method is used to verify the integrity of the specimen collection process. |
30 | $12 | $45 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
21 | $135 | $420 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
18 | $110 | $268 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
14 | $137 | $214 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
12 | $200 | $652 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$9,615
Total received (2018-2024)
Avg $1,374/year across 7 years
Top 6% in GA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
67
Companies
594
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,615 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,978
2023
$2,262
2022
$1,998
2021
$1,639
2020
$866
2019
$476
2018
$396
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$220
Novo Nordisk Inc
$217
Lilly USA, LLC
$214
Bayer Healthcare Pharmaceuticals Inc.
$157
ABBVIE INC.
$130
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$129
AstraZeneca Pharmaceuticals LP
$104
Astellas Pharma US Inc
$88
PFIZER INC.
$86
Otsuka America Pharmaceutical, Inc.
$76
Collegium Pharmaceutical, Inc.
$66
Insulet Corporation
$52
GlaxoSmithKline, LLC.
$49
Antares Pharma, Inc.
$47
Indivior Inc.
$46
Abbott Laboratories
$46
Novartis Pharmaceuticals Corporation
$41
Phathom Pharmaceuticals, Inc.
$31
Ardelyx, Inc.
$24
Mannkind Corporation
$23
Janssen Pharmaceuticals, Inc
$23
Sumitomo Pharma America, Inc.
$22
Lundbeck LLC
$21
Kowa Pharmaceuticals America, Inc.
$18
Boehringer Ingelheim Pharmaceuticals, Inc.
$17
Exact Sciences Corporation
$16
Tolmar, Inc.
$15
Top 3 companies account for 32.9% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$1,057
Lilly USA, LLC
$779
Amgen Inc.
$658
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$528
AbbVie Inc.
$511
AstraZeneca Pharmaceuticals LP
$492
ABBVIE INC.
$449
PFIZER INC.
$365
Novartis Pharmaceuticals Corporation
$362
GlaxoSmithKline, LLC.
$329
Corium, LLC
$313
Bayer Healthcare Pharmaceuticals Inc.
$294
Antares Pharma, Inc.
$261
Astellas Pharma US Inc
$252
Amarin Pharma Inc.
$240
Vanda Pharmaceuticals Inc.
$178
Otsuka America Pharmaceutical, Inc.
$175
Sunovion Pharmaceuticals Inc.
$161
Abbott Laboratories
$146
Janssen Pharmaceuticals, Inc
$135
Teva Pharmaceuticals USA, Inc.
$132
SANOFI-AVENTIS U.S. LLC
$101
Biohaven Pharmaceutical Holding Company Ltd.
$98
Insulet Corporation
$94
Ironwood Pharmaceuticals, Inc
$89
Sumitomo Pharma America, Inc.
$68
Boehringer Ingelheim Pharmaceuticals, Inc.
$68
Collegium Pharmaceutical, Inc.
$66
Merck Sharp & Dohme Corporation
$66
Kowa Pharmaceuticals America, Inc.
$65
Takeda Pharmaceuticals U.S.A., Inc.
$63
Lundbeck LLC
$59
Eisai Inc.
$53
Allergan Inc.
$51
Supernus Pharmaceuticals, Inc.
$48
Allergan, Inc.
$47
Indivior Inc.
$46
Grifols USA, LLC
$45
IDORSIA PHARMACEUTICALS US INC
$41
Nestle HealthCare Nutrition Inc.
$38
Xeris Pharmaceuticals, Inc.
$37
Arbor Pharmaceuticals, Inc.
$37
Tolmar, Inc.
$36
Medtronic MiniMed, Inc.
$36
Dexcom, Inc.
$36
Bayer HealthCare Pharmaceuticals Inc.
$33
Phathom Pharmaceuticals, Inc.
$31
Medtronic, Inc.
$28
Ardelyx, Inc.
$24
EISAI INC.
$24
Mannkind Corporation
$23
Synergy Pharmaceuticals Inc
$23
ACADIA Pharmaceuticals Inc
$21
Biogen, Inc.
$19
Clarus Therapeutics Inc.
$17
DePuy Synthes Sales Inc.
$17
IRONWOOD PHARMACEUTICALS, INC
$17
Paratek Pharmaceuticals, Inc.
$16
Exact Sciences Corporation
$16
Nabriva Therapeutics, plc
$15
AbbVie, Inc.
$14
Endo Pharmaceuticals Inc.
$14
Melinta Therapeutics, Inc.
$13
ARBOR PHARMACEUTICALS, INC.
$12
Medtronic USA, Inc.
$12
Aytu BioScience, Inc
$11
Horizon Pharma plc
$11
Top 3 companies account for 25.9% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ADVAIR · AFREZZA · AIMOVIG · AIRSUPRA · AJOVY · APTIOM · AREXVY · AUSTEDO · AZSTARYS · Aimovig · Androgel · Azstarys · BREZTRI · BREZTRI AEROSPHERE · Belbuca · CHANTIX · COMIRNATY · CUVITRU · Cologuard Collection Kit · DAYBUE · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Edarbi · FARXIGA · FREESTYLE LIBRE · FreeStyle Libre · GEMTESA · GVOKE PFS · HETLIOZ · HUMIRA · IBSRELA · INTERSTIM · JANUVIA · JARDIANCE · JATENZO · KEVEYIS · KRYSTEXXA · KYPHON EXPRESS II KYPHOPAK TRAY · Kerendia · LEQVIO · LINZESS · LOKELMA · LONHALA MAGNAIR · LYRICA · Linzess · Livalo · MONOVISC · MOUNJARO · MYRBETRIQ · Minimed 670G System · NASCOBAL · NOCDURNA · NURTEC ODT · NUZYRA · Natesto · OTREXUP · Omnipod · Orbactiv · Otezla · Otrexup · Ozempic · PENNSAID · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Prolastin-C · Prolastin-C Liquid · Prolia · QELBREE · QULIPTA · QUVIVIQ · REXULTI · REYVOW · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA 100/33 · SPINRAZA · SPRAVATO · SUBLOCADE · SYMBICORT · SYNTHROID · Saxenda · Sivextro · TLANDO · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Tresiba · Trintellix · Trulance · UBRELVY · VESICARE · VIBERZI · VOQUEZNA · VRAYLAR · Vascepa · Veozah · Wegovy · XARELTO · XIFAXAN · XYOSTED · ZENPEP · ZEPBOUND · ZORYVE
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for family medicine in GA.
Geographic Context
Family medicine physicians within 10 mi
180
Per 100K population
107.8
County median income
$80,743
Nearest hospital
EMORY HOUSTON HOSPITAL WARNER ROBINS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Aguila is a clinical cardiology specialist, with above-average Medicare volume (top 4% in GA), with low-engagement industry engagement in the top 6% of GA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Aguila experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Aguila performed 947 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Aguila receive payments from pharmaceutical companies?
Yes. Dr. Aguila received a total of $9,615 from 67 companies across 594 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Aguila's costs compare to other family medicine physicians in Warner Robins?
Dr. Aguila's average Medicare payment per service is $47. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Aguila) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Warner Robins
Browse family medicine physicians in Warner Robins ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in GA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in GA
Which GA family medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology